It is caused by the heightened demand for blood flow in muscles
when it occurs, it is often secondary to other factors related to the medication's effects or individual patient circumstances
doi: 10.3389/fphar.2024.1467788 Received 20 July 2024 Accepted 06 November 2024 Published 25 November 2024 Volume 15 - 2024 Edited by Jian Hao, The Second Affiliated Hospital of Guangzhou Medical University, China Reviewed by Geovanna Nallely Quionez-Bastidas, Autonomous University of Sinaloa, Mexico Wei Xiong, MGI Tech Co., Ltd., China Updates Copyright 2024 Hashemi, Fakhri, Kiani, Abbaszadeh, Miraghaee, Mohammadi and Echeverra
American journal of kidney diseases [Available on 1st August 1998] [Accessed on 19th July 2022] 3
In most cases, injectable GLP-1 agonists can reduce blood sugar levels as much as daily insulin injections